FLUAD® with MF59® Adjuvant is a flu vaccine designed to strengthen, broaden, and lengthen the duration of the immune response and is approved for patients 65+. Visit flu360.com to learn more.
More susceptible to influenza2,3 Less able to generate a sufficient immune response to standard flu vaccines2,3 Can decrease vaccine effectiveness especially in an already vulnerable population4,5 7 out of 10 recent US flu seasons were impacted by strain mismatch*5-15 ...